2023 Archived Content

Agenda

SCOPE's Clinical Trial Tech: Venture, Innovation, & Partnering Conference

February 7, 2023 ALL TIMES EST

SCOPE's Clinical Trial Tech: Venture, Innovation, & Partnering Conference will take place in conjunction with the 14th annual SCOPE Summit (Summit for Clinical Ops Executives). We are excited to add this new conference to an already established and successful event of over 2,300 leaders in clinical operations and research. The Venture, Innovation, & Partnering Conference aims to bring together C-level executives from investment firms that support innovation in the clinical trial process, strategics from pharmaceutical and leading CROs, both venture and corporate arms who have a vested interested in driving this innovation, and also CEOs and innovators from industry, driving the technology in this space. This unique combination of events offers the opportunity to participate in a venture and partnering event featuring a very exciting and emerging tech space, while also offering the chance to visit the exhibit hall and meet companies and get a sense of where this industry is going.

Monday, February 6

8:00 am

SCOPE’s 2nd Annual Masters of Clinical Research Golf Tournament* (Sponsorship Opportunities Available)

Connect with your peers and colleagues at SCOPE's 2nd Annual Masters of Clinical Research Golf Tournament. For more information on participating or how you can get involved as a sponsor, please visit the SCOPE Summit website for further details.

*Limited space available. Separate registration and fee required for Golf.

6:30 pm

SCOPE's Kick-Off Happy Hour

Tuesday, February 7

7:00 am

Registration Open (Gatlin Foyer)

7:30 am

Networking Breakfast

8:20 am

Co-Chair Welcome Address

Jessica J. Federer, Managing Partner, Supernode Ventures

8:30 am

Fostering a Collaborative Clinical Technology Ecosystem to Accelerate Innovation

How can innovative companies work together to bridge the silos across clinical development and drive significant value for life science companies, investors, and patients? How should the latest CEO priorities influence your clinical trial tech agenda? How does Accenture identify investment opportunities?

8:50 am

Panel One:

What Are the Most Exciting Areas for Investment When It Comes to the Future of Clinical Trials: Perspectives from Different Investors

PANEL MODERATOR:

Eric M. Snyder, Partner, Novo Ventures (US), Inc.

Where are investors putting their investment and what are the exciting technologies? How are we dealing with Valuations in today’s market? What are the main themes that each investor is following? Which of the technologies are priority for each investor type (technologies in patient recruitment, decentralized, automation, digital twin, digital biomarkers)? For strategics, how do they approach partnering with investors?

PANELISTS:

Jennifer Levin Carter, Managing Director, The Blue Venture Fund

Sunny Kumar, Partner, GSR Ventures

Robert Thwaits, Managing Director, Declaration Partners

Jessica J. Federer, Managing Partner, Supernode Ventures

9:35 am

Panel Two:

What’s the ROI for Clinical Trial Innovation Investing for Different Types of Investors?

PANEL MODERATOR:

Konstantina Katcheves, Senior Vice President, Business Development, Bristol Myers Squibb Co.

This panel will share perspectives from strategic investors, VCs, and more as they explore the value that new clinical trial approaches, including DCT, bring to the broader ecosystem. Can these innovative companies support existing valuations? What is the motivation of the different investors in the space?

PANELISTS:

Michael Sorensen, Partner, QHP Capital

Manu Nair, Chair, US Clinical Practice and High Value Opportunities, Corporate Development, Mayo Clinic

Joe O'Rourke, Head of Commercial Development, Walgreens Clinical Trials

Brittany Erana, Senior Vice President, Digital & Decentralized Solutions, PPD Part of Thermo Fisher Scientific

10:20 am

Networking Coffee Break

10:50 am

Panel Three:

Bridging the Chasm of Research and Care: How Is the Landscape Evolving for Investors and Start-Ups?

PANEL MODERATOR:

Jared Saul, Global Head, Healthcare + Life Sciences, Amazon Web Services LLC

We’ve all seen the news of Amazon + OneMedical, and CVS and Signify. What do the investments in care mean for research? And as the ecosystem evolves to a more integrated tech-enabled approach to care and research, what does that mean for start-ups and investors moving forward. This panel will also cover how technology, including platforms, wearables, homecare, monitoring etc., is enabling this integration, automations, and better inclusion. Can tech finally help us bridge the gap between research and care and move to an integrated, seamless approach?

PANELISTS:

Tony Clapsis, General Manager and Senior Vice President, CVS Health Clinical Trial Services

Jennifer Byrne, CEO, Javara, Inc.

Michael A. Greeley, Co-Founder & General Partner, Healthcare Technology, Flare Capital Partners

Fei Shen, PhD, Managing Director, Boehringer Ingelheim Venture Fund

Jodi Akin, Founder and CEO, Hawthorne Effect, Inc.

11:35 am

CEO Spotlight Part One:

How Are CEOs and Founding Teams of Innovative Companies in the Clinical Trial Space Overcoming Hurdles to Fundraising, Pilots, and Scaling?

PANEL MODERATOR:

Jeff Kozloff, Board Member: ProofPilot, VersaTrial, Lokavant, Signallamp Health

Joseph Munda, Senior Vice President Research & Venture, First Analysis Corp.

What has it been like fundraising at this time? What is it like to be a CEO at this time? What was your last raise like? What experience do you want to share about working with your investors? What has it been like to raise capital in this market crash?

PANELISTS:

Charles K. Fisher, Founder & CEO, Unlearn.AI, Inc.

Rust Felix, Co-Founder & CEO, Slope

Ruby Gadelrab Tudor, CEO & Founder, MDisrupt

Ivor Clarke, CEO, SubjectWell

12:15 pm

Networking Luncheon

1:50 pm

Co-Chair Afternoon Address

Jodi Akin, Founder and CEO, Hawthorne Effect, Inc.

2:00 pm

Panel Four:

Are We Getting Closer to the Holy Grail of Data Quality?

PANEL MODERATOR:

George Mathew, Chief Medical Officer, North America, Dedalus

This panel will explore investments and innovation into the data space, including interoperability, synthetic control arms, digital biomarkers, and the regulator perspective and why data quality is the holy grail of our industry.

PANELISTS:

Ryan Jones, CEO, Florence Healthcare

Derk Arts, Founder & CEO, Castor

Joy Bhosai, Founder & CEO, Pluto Health

2:45 pm

Networking Coffee Break

3:40 pm

Panel Five:

Can We Shorten the Long Arc of Investing in the Clinical Trial Space?

PANEL MODERATOR:

Evan Norton, Founder & Managing Partner, SPRIG Equity

How do We Scale Companies? This panel will explore the timelines of company growth and scale in the complex clinical trial space. Companies need to scale to be relevant enough to IPO, what is the growth trajectory for any given company?

PANELISTS:

Carrie Williams, Vice President & Partner, McKesson Ventures

Bari Kowal, Senior Vice President & Head, Development Operations & Portfolio Management, Global Development, Regeneron Pharmaceuticals, Inc.

Dave Stevenson, COO & Managing Director, Merck Global Health Innovation Fund

Nick Slack, Executive in Residence Warburg Pincus, former President WCG Clinical

4:25 pm

Publication Spotlight: Growing Health Tech Businesses: Learnings from Studying how Best-in-Class Healthcare SaaS and Tech-Enabled Services Companies Scale

4:40 pm

CEO Spotlight Part Two:

How Are CEOs and Founding Teams of Innovative Companies in the Clinical Trial Space Overcoming Hurdles to Fundraising, Pilots, and Scaling?

PANEL MODERATOR:

Thorsten Wirkes, Senior Vice President, Bertelsmann Next, Bertelsmann Investments

What has it been like fundraising at this time? What is it like to be a CEO at this time? What was your last raise like? What experience do you want to share about working with your investors? What has it been like to raise capital in this market crash?

PANELISTS:

Wout Brusselaers, CEO, Deep 6 AI

David MacMurchy, CEO, Lightship

Matt J. Walz, CEO, Trialbee

Hala Borno, MD, CEO, Trial Library

Sumeet Singh, Founder & CEO, Lighthouse

5:20 pm

Co-Chair Closing Address

Konstantina Katcheves, Senior Vice President, Business Development, Bristol Myers Squibb Co.

5:30 pm

Networking Reception

7:00 pm

Close of Investor/Innovation Conference (You Are Welcome to Visit the SCOPE Conference – Feb. 8-9)